Jenny Lam

876 total citations
40 papers, 565 citations indexed

About

Jenny Lam is a scholar working on Atomic and Molecular Physics, and Optics, Pulmonary and Respiratory Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Jenny Lam has authored 40 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Atomic and Molecular Physics, and Optics, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Jenny Lam's work include Quantum optics and atomic interactions (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Atomic and Subatomic Physics Research (6 papers). Jenny Lam is often cited by papers focused on Quantum optics and atomic interactions (9 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers) and Atomic and Subatomic Physics Research (6 papers). Jenny Lam collaborates with scholars based in United States, Canada and United Kingdom. Jenny Lam's co-authors include D. G. Steel, R. C. Lind, R. A. McFarlane, Soeren Mattke, Joanne Cleland, C. R. Giuliano, Keith A. Betts, David D. Stenehjem, Solomon J. Lubinga and Yong Yuan and has published in prestigious journals such as Physical Review Letters, SHILAP Revista de lepidopterología and Applied Physics Letters.

In The Last Decade

Jenny Lam

36 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jenny Lam United States 15 240 104 98 73 59 40 565
Shu Ou United States 20 159 0.7× 33 0.3× 57 0.6× 21 0.3× 32 0.5× 53 910
Sylwia Bujkiewicz United Kingdom 18 242 1.0× 32 0.3× 36 0.4× 39 0.5× 20 0.3× 63 965
Ségolène Gaillard France 18 182 0.8× 129 1.2× 18 0.2× 61 0.8× 23 0.4× 64 1.1k
Edward J. Moler United States 16 158 0.7× 11 0.1× 80 0.8× 72 1.0× 24 0.4× 38 956
M. Williams United States 16 138 0.6× 20 0.2× 21 0.2× 220 3.0× 70 1.2× 34 777
Aki Kuroda Japan 11 159 0.7× 161 1.5× 143 1.5× 15 0.2× 10 0.2× 23 679
Lee‐Shing Chang United States 10 528 2.2× 42 0.4× 284 2.9× 385 5.3× 35 0.6× 17 1.1k
Zhengjun Li China 19 195 0.8× 93 0.9× 29 0.3× 29 0.4× 3 0.1× 55 794
Elizabeth Kurian India 18 64 0.3× 83 0.8× 69 0.7× 15 0.2× 64 1.1× 63 986
Johan Nilsson Sweden 11 163 0.7× 16 0.2× 61 0.6× 93 1.3× 67 1.1× 30 599

Countries citing papers authored by Jenny Lam

Since Specialization
Citations

This map shows the geographic impact of Jenny Lam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jenny Lam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jenny Lam more than expected).

Fields of papers citing papers by Jenny Lam

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jenny Lam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jenny Lam. The network helps show where Jenny Lam may publish in the future.

Co-authorship network of co-authors of Jenny Lam

This figure shows the co-authorship network connecting the top 25 collaborators of Jenny Lam. A scholar is included among the top collaborators of Jenny Lam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jenny Lam. Jenny Lam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lam, Jenny, Kanetee Busiah, Peter Kopp, et al.. (2025). Prevalence and Impact of Partial Anomalous Pulmonary Venous Connection in Turner Syndrome. PubMed. 4(6). 330–337.
2.
Sauer, Andrew J., Kensey Gosch, Suzanne V. Arnold, et al.. (2024). The Psychometric Performance of the Kansas City Cardiomyopathy Questionnaire-12 in Symptomatic Obstructive Hypertrophic Cardiomyopathy. Journal of Cardiac Failure. 31(5). 813–820. 2 indexed citations
3.
Lam, Jenny, Nicole Sekarski, Tobias Rutz, et al.. (2023). Turner syndrome: skin, liver, eyes, dental and ENT evaluation should be improved. Frontiers in Endocrinology. 14. 1190670–1190670. 1 indexed citations
4.
Lam, Jenny, et al.. (2023). Unusual Case of LIMA Graft to Pulmonary Artery Fistula Causing Coronary Steal Syndrome. Heart Lung and Circulation. 32. S311–S311. 1 indexed citations
5.
Jun, Hankyung, et al.. (2022). Association of cash payment with intensity of opioid prescriptions. Journal of the American Pharmacists Association. 62(4). 1224–1231.e5.
6.
Stenehjem, David D., Solomon J. Lubinga, Keith A. Betts, et al.. (2021). Treatment Patterns in Patients with Metastatic Non-Small-Cell Lung Cancer in the Era of Immunotherapy. Future Oncology. 17(22). 2940–2949. 14 indexed citations
7.
Waterhouse, David, Jenny Lam, Keith A. Betts, et al.. (2021). Real-world outcomes of immunotherapy–based regimens in first-line advanced non-small cell lung cancer. Lung Cancer. 156. 41–49. 88 indexed citations
8.
Hoben, Matthias, Stephanie Chamberlain, Hannah M. O’Rourke, et al.. (2021). Psychometric properties and use of the DEMQOL suite of instruments in research: a systematic review protocol. BMJ Open. 11(2). e041318–e041318. 4 indexed citations
9.
Lam, Jenny, Ivy Tonnu-Mihara, Nicholas J. Kenyon, & Brooks Kuhn. (2021). Comparative Effectiveness of Roflumilast and Azithromycin for the Treatment of Chronic Obstructive Pulmonary Disease. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 8(4). 450–463. 3 indexed citations
10.
Hoben, Matthias, Sube Banerjee, Anna Beeber, et al.. (2021). Feasibility of Routine Quality of Life Measurement for People Living With Dementia in Long-Term Care. Journal of the American Medical Directors Association. 23(7). 1221–1226. 7 indexed citations
11.
Waterhouse, David, Jenny Lam, Keith A. Betts, et al.. (2021). Real-world progression-free survival in first-line advanced non-small cell lung cancer treated with immunotherapy-based regimens using a US dataset. SHILAP Revista de lepidopterología. 37. 107195–107195. 3 indexed citations
12.
Lam, Jenny, Jakub Hlávka, & Soeren Mattke. (2019). The Potential Emergence of Disease-Modifying Treatments for Alzheimer Disease: The Role of Primary Care in Managing the Patient Journey. The Journal of the American Board of Family Medicine. 32(6). 931–940. 18 indexed citations
13.
Lam, Jenny, et al.. (2019). Systematic review of ultrasound visual biofeedback in intervention for speech sound disorders. International Journal of Language & Communication Disorders. 54(5). 705–728. 49 indexed citations
14.
Lam, Jenny, Joel W. Hay, Jonathan Salcedo, & Nicholas J. Kenyon. (2018). A cost-effectiveness analysis of reslizumab in the treatment of poorly controlled eosinophilic asthma. Journal of Asthma. 56(8). 872–881. 16 indexed citations
15.
Lam, Jenny, et al.. (2018). Real-World Treatment Patterns And Care Pathways In Metastatic Castration Resistant Prostate Cancer. Value in Health. 21. S41–S41. 3 indexed citations
16.
Lam, Jenny, et al.. (2018). An Evaluation of the Cost-Effectiveness of Reslizumab in Poorly Controlled Eosinophilic Asthma. Value in Health. 21. S235–S235. 1 indexed citations
17.
18.
Salcedo, Jonathan, Joel W. Hay, & Jenny Lam. (2018). Cost-effectiveness of rivaroxaban versus warfarin for treatment of nonvalvular atrial fibrillation in patients with worsening renal function. International Journal of Cardiology. 282. 53–58. 14 indexed citations
19.
Dorian, Paul, et al.. (2018). EVALUATION OF HEART RATE TRACKERS IN PATIENTS WITH ATRIAL FIBRILLATION. Canadian Journal of Cardiology. 34(10). S152–S153. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Shu Ou Breakdown of academic impact, for papers by Sylwia Bujkiewicz Breakdown of academic impact, for papers by Ségolène Gaillard Breakdown of academic impact, for papers by Edward J. Moler Breakdown of academic impact, for papers by M. Williams Breakdown of academic impact, for papers by Aki Kuroda Breakdown of academic impact, for papers by Lee‐Shing Chang Breakdown of academic impact, for papers by Zhengjun Li Breakdown of academic impact, for papers by Elizabeth Kurian Breakdown of academic impact, for papers by Johan Nilsson
Rankless by CCL
2026